Back

Optimisation of cardiovascular risk factors in a dedicated cardio-oncology clinic for men with prostate cancer commencing androgen deprivation therapy

19 June 2026 (08:30 - 17:30)
Organised by: Logo
Congress Presentation Part of: Poster session (1) Diagnosis and Management of Cardiovascular Disease in Patients with Cancer CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Hock Shyong Yap

Victorian Heart Hospital, Clayton (Australia)

45 More presentations in this session

Presentation thumbnail
Exploring lipoprotein(a) and incident heart failure in cancer patients with anthracycline-associated neoplasms
Mrs A. Stephanus (Brasilia, BR)
Abstract Slides
Presentation thumbnail
ICARE-TNBC : Immune checkpoint-associated cardiotoxicity risk evaluation in early-stage triple-negative breast cancer
Miss L. Dib (Paris, FR)
Abstract
Presentation thumbnail
Incidence and risk profile of venous thromboembolic events in patients undergoing immune checkpoint inhibitor therapy
Doctor Z. Sandor (Budapest, HU)
Abstract Slides
Presentation thumbnail
Pericoronary fat attenuation on coronary ct identifies persistent vascular inflammation after chest radiotherapy in cancer survivors
Doctor T. De Silva (London, GB)
Abstract Slides
Presentation thumbnail
Optimizing troponin T screening for immune checkpoint inhibitor-associated myocarditis
Mr T. Uyl (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster session (1)

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients
21 May 2023
thumbnail
Congress Presentation
Androgen deprivation therapy with agonists of GnRH: cardiovascular adverse events and comorbidity considerations in patients with prostate cancer
27 August 2021
thumbnail
Webinar
Understanding the cardiovascular risks in prostate cancer treatment
18 November 2025
thumbnail
Congress Presentation
Prognostic impact of coronary artery calcifications in patients with newly diagnosed prostate cancer
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources